Back to TARS
Vestal Point Capital, LP → TARS
Vestal Point Capital, LP TARS Position History
Tarsus Pharmaceuticals, Inc. • Healthcare
Quarters held
3
Latest value
$159.9M
Q3 2026
Peak value
$159.9M
First seen
Q1 2026
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2026 | $14M |
| Q2 2026 | $66.1M |
| Q3 2026 | $159.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $159.9M | 2.03M | — | — |
| Q2 2026 | $66.1M | 1.05M | — | — |
| Q1 2026 | $14M | 200.0K | — | — |
Other funds holding TARS
$299.3M
$273.9M
$273.1M
$252.5M
$234.7M
$230.8M
$220.2M